Quarterly report pursuant to Section 13 or 15(d)

Common Stock and Employee Equity Plans (Tables)

v3.23.1
Common Stock and Employee Equity Plans (Tables) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
Apr. 01, 2023
Mar. 26, 2022
Equity [Abstract]    
Schedule of Common Shares Outstanding
Common Stock
Shares of common stock outstanding were as follows:
Three Months Ended
April 1,
2023
March 26,
2022
(In millions)
Balance, beginning of period 1,612  1,207 
Common stock issued in the acquisition of Xilinx —  429 
Common stock issued under employee equity plans
Common stock repurchases for tax withholding on equity awards (1) (1)
Repurchases of common stock (3) (16)
Balance, end of period 1,609  1,620 
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based Compensation
Stock-based compensation expense recorded in the Condensed Consolidated Statements of Operations was as follows: 
Three Months Ended
April 1,
2023
March 26,
2022
(In millions)
Cost of sales $ $
Research and development 214  113 
Marketing, general and administrative 87  82 
Total $ 309  $ 199 
 
Stock Repurchased During Period, Shares 3,000  
Payments for Repurchase of Common Stock $ 241 $ 1,914